🇺🇸 FDA
Patent

US 11617771

Oral composition comprising lactic acid bacteria for regulating immune responses and methods related thereto

granted A61KA61K2035/115A61K2239/31

Quick answer

US patent 11617771 (Oral composition comprising lactic acid bacteria for regulating immune responses and methods related thereto) held by The Regents of the University of California expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2035/115, A61K2239/31, A61K2239/38, A61K2239/54